1832 Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-105,199
Closed -$7.79M 672
2024
Q4
$7.79M Sell
105,199
-150,245
-59% -$10.5M 0.01% 337
2024
Q3
$16.9M Sell
255,444
-22,014
-8% -$1.6M 0.03% 302
2024
Q2
$25.6M Sell
277,458
-29,839
-10% -$2.64M 0.05% 253
2024
Q1
$29.4M Sell
307,297
-385,935
-56% -$32.4M 0.05% 226
2023
Q4
$52.9M Sell
693,232
-107,143
-13% -$7.46M 0.1% 176
2023
Q3
$55.4M Buy
800,375
+23,095
+3% +$1.86M 0.12% 158
2023
Q2
$73.3M Sell
777,280
-34,115
-4% -$2.97M 0.14% 134
2023
Q1
$67.1M Buy
811,395
+5,865
+0.7% +$461K 0.14% 156
2022
Q4
$60.1M Sell
805,530
-39,925
-5% -$3.08M 0.12% 168
2022
Q3
$69.9M Sell
845,455
-15,295
-2% -$1.47M 0.15% 150
2022
Q2
$81.8M Sell
860,750
-13,846
-2% -$1.43M 0.16% 134
2022
Q1
$102M Buy
874,596
+118,765
+16% +$13.3M 0.17% 126
2021
Q4
$99.5M Sell
755,831
-655,093
-46% -$76.4M 0.18% 119
2021
Q3
$161M Sell
1,410,924
-179,516
-11% -$20.5M 0.3% 88
2021
Q2
$164M Buy
1,590,440
+957,333
+151% +$90.2M 0.32% 86
2021
Q1
$52.7M Buy
633,107
+2,675
+0.4% +$226K 0.11% 167
2020
Q4
$56.8M Sell
630,432
-60,870
-9% -$5.05M 0.13% 146
2020
Q3
$54.6M Buy
+691,302
New +$53.9M 0.14% 133
2020
Q2
Sell
-238,152
Closed -$15.6M 672
2020
Q1
$15.6M Sell
238,152
-29,820
-11% -$2.15M 0.06% 198
2019
Q4
$20.9M Buy
267,972
+137,607
+106% +$10.7M 0.06% 187
2019
Q3
$9.44M Buy
130,365
+122,169
+1,491% +$8.58M 0.03% 234
2019
Q2
$507K Buy
8,196
+8,100
+8,438% +$490K ﹤0.01% 500
2019
Q1
$6K Hold
96
﹤0.01% 590
2018
Q4
$5K Hold
96
﹤0.01% 582
2018
Q3
$6K Hold
96
﹤0.01% 607
2018
Q2
$5K Buy
+96
New +$4.48K ﹤0.01% 603
2018
Q1
Sell
-60
Closed -$2K 691
2017
Q4
$2K Buy
+60
New +$2.2K ﹤0.01% 662
2017
Q2
Sell
-7,875
Closed -$247K 683
2017
Q1
$247K Sell
7,875
-1,721,319
-100% -$53.9M ﹤0.01% 526
2016
Q4
$66M Buy
1,729,194
+6,594
+0.4% +$214K 0.11% 181
2016
Q3
$67.3M Buy
+1,722,600
New +$64.9M 0.25% 98

Other funds holding EW